Our Journey Beyond Sunset Boulevard : : evidence-based analysis of tumor-targeted gene- & immuno-therapies shine a critical spotlight on "true" long-term cancer-free survival / / by Erlinda M. Gordon and Frederick L. Hall.

• VerfasserIn: Gordon, Erlinda M.,; Hall, Frederick L.,
• TeilnehmendeR: Hall, Frederick L.,
• Place / Publishing House: London : : IntechOpen,, 2021.; ©2021
• Year of Publication: 2021
• Language: English
• Physical Description: 1 online resource (xii, 56 pages) :; illustrations

The revival of DeltaRex-G (formerly Rexin-G)-the first proactive tumor-hunting/tumor-killing biomedicine of this kind in history-returned active tumor surveillance and a precision-guided "silver bullet" (dnG1 killer gene) to the cancer clinic with "Expanded Access" in 2019. Empowered by US Right-to-Try legislation, while honoring ethical principles of "informed consent," this unique graphic/picturesque presentation of clinical and translational medicine is intended for postmodern (post-Enlightenment) layman readers, including cancer patients, students, researchers, and future practitioners in the field of precision gene-based medicine. Confronting logical fallacies in popular opinion, the authors present newsworthy, up-to-date clinical research documenting the successful management of refractory metastatic cancers with tumor-targeted gene therapy vectors-validating "pathotropic" (disease-seeking) tumor targeting avant la lettre.